|
1
|
Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence.
|
J Immunol
|
2007
|
3.24
|
|
2
|
Rapid emergence of protease inhibitor resistance in hepatitis C virus.
|
Sci Transl Med
|
2010
|
2.82
|
|
3
|
Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.
|
Hepatology
|
2003
|
2.50
|
|
4
|
Kinetics of hepatitis C virus reinfection after liver transplantation.
|
Liver Transpl
|
2006
|
2.01
|
|
5
|
Triphasic decline of hepatitis C virus RNA during antiviral therapy.
|
Hepatology
|
2007
|
2.00
|
|
6
|
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.
|
PLoS Pathog
|
2010
|
1.99
|
|
7
|
Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates.
|
Blood
|
2012
|
1.91
|
|
8
|
Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy.
|
J Theor Biol
|
2007
|
1.89
|
|
9
|
Cutting edge: Experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion.
|
J Immunol
|
2008
|
1.82
|
|
10
|
Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection.
|
J Virol
|
2004
|
1.77
|
|
11
|
Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin.
|
J Hepatol
|
2007
|
1.74
|
|
12
|
Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders.
|
Hepatology
|
2006
|
1.69
|
|
13
|
Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus.
|
Eur J Immunol
|
2005
|
1.60
|
|
14
|
The level of monocyte turnover predicts disease progression in the macaque model of AIDS.
|
Blood
|
2009
|
1.59
|
|
15
|
Division-linked differentiation can account for CD8+ T-cell phenotype in vivo.
|
Eur J Immunol
|
2009
|
1.51
|
|
16
|
Modeling amantadine treatment of influenza A virus in vitro.
|
J Theor Biol
|
2008
|
1.51
|
|
17
|
Simian immunodeficiency virus SIVagm dynamics in African green monkeys.
|
J Virol
|
2008
|
1.49
|
|
18
|
Real time bayesian estimation of the epidemic potential of emerging infectious diseases.
|
PLoS One
|
2008
|
1.46
|
|
19
|
Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.
|
J Virol
|
2006
|
1.44
|
|
20
|
Modeling the within-host dynamics of HIV infection.
|
BMC Biol
|
2013
|
1.29
|
|
21
|
Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.
|
PLoS Pathog
|
2012
|
1.28
|
|
22
|
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.
|
J Infect Dis
|
2003
|
1.27
|
|
23
|
Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver.
|
Gastroenterology
|
2013
|
1.23
|
|
24
|
Influence of peak viral load on the extent of CD4+ T-cell depletion in simian HIV infection.
|
J Acquir Immune Defic Syndr
|
2006
|
1.23
|
|
25
|
Modeling HCV kinetics under therapy using PK and PD information.
|
Expert Opin Drug Metab Toxicol
|
2009
|
1.22
|
|
26
|
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells.
|
J Virol
|
2006
|
1.21
|
|
27
|
The role of cells refractory to productive infection in acute hepatitis B viral dynamics.
|
Proc Natl Acad Sci U S A
|
2007
|
1.19
|
|
28
|
Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b.
|
Semin Liver Dis
|
2003
|
1.18
|
|
29
|
Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.
|
Epidemics
|
2012
|
1.18
|
|
30
|
Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae.
|
PLoS Pathog
|
2013
|
1.16
|
|
31
|
Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues.
|
PLoS Comput Biol
|
2010
|
1.15
|
|
32
|
Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus.
|
J Virol
|
2007
|
1.15
|
|
33
|
Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication.
|
J Clin Invest
|
2014
|
1.14
|
|
34
|
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.
|
Math Biosci
|
2004
|
1.14
|
|
35
|
Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity.
|
J Virol
|
2010
|
1.14
|
|
36
|
Understanding the mechanisms and limitations of immune control of HIV.
|
Immunol Rev
|
2007
|
1.13
|
|
37
|
A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease.
|
Gastroenterology
|
2009
|
1.11
|
|
38
|
Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx).
|
J Virol
|
2011
|
1.09
|
|
39
|
Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host.
|
J Virol
|
2009
|
1.09
|
|
40
|
Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion.
|
PLoS Pathog
|
2011
|
1.08
|
|
41
|
Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
|
Antivir Ther
|
2007
|
1.08
|
|
42
|
Modeling the viral dynamics of influenza A virus infection.
|
Crit Rev Immunol
|
2010
|
1.07
|
|
43
|
High-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8+ T-cell expansion but improved virus control.
|
J Virol
|
2005
|
1.05
|
|
44
|
Modeling complex decay profiles of hepatitis B virus during antiviral therapy.
|
Hepatology
|
2009
|
1.05
|
|
45
|
Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections.
|
J Virol
|
2008
|
1.02
|
|
46
|
Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics.
|
PLoS Comput Biol
|
2011
|
1.02
|
|
47
|
Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus.
|
J Virol
|
2004
|
1.01
|
|
48
|
A hepatitis C viral kinetic model that allows for time-varying drug effectiveness.
|
Antivir Ther
|
2008
|
1.00
|
|
49
|
Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection.
|
J Immunol
|
2002
|
0.99
|
|
50
|
The race between infection and immunity: how do pathogens set the pace?
|
Trends Immunol
|
2009
|
0.98
|
|
51
|
Modelling deuterium labelling of lymphocytes with temporal and/or kinetic heterogeneity.
|
J R Soc Interface
|
2012
|
0.97
|
|
52
|
Hepatitis B virus kinetics and mathematical modeling.
|
Semin Liver Dis
|
2004
|
0.95
|
|
53
|
Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.
|
J Acquir Immune Defic Syndr
|
2004
|
0.94
|
|
54
|
Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections.
|
PLoS Pathog
|
2013
|
0.93
|
|
55
|
Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.
|
Retrovirology
|
2010
|
0.93
|
|
56
|
Modeling the mechanisms of acute hepatitis B virus infection.
|
J Theor Biol
|
2007
|
0.92
|
|
57
|
Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients.
|
J Infect Dis
|
2005
|
0.91
|
|
58
|
Evolution of drug-resistant viral populations during interruption of antiretroviral therapy.
|
J Virol
|
2011
|
0.89
|
|
59
|
The evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal data.
|
Epidemics
|
2009
|
0.89
|
|
60
|
Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination.
|
J Virol
|
2004
|
0.89
|
|
61
|
Mathematical modeling of viral kinetics: a tool to understand and optimize therapy.
|
Clin Liver Dis
|
2003
|
0.88
|
|
62
|
Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitor.
|
Bull Math Biol
|
2012
|
0.88
|
|
63
|
Mathematical modeling of HCV infection and treatment.
|
Methods Mol Biol
|
2009
|
0.87
|
|
64
|
Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models.
|
Front Immunol
|
2013
|
0.86
|
|
65
|
Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infections.
|
BMC Bioinformatics
|
2010
|
0.85
|
|
66
|
Mutagenic effects of ribavirin in vivo.
|
J Hepatol
|
2005
|
0.83
|
|
67
|
Estimating drug efficacy and viral dynamic parameters: HIV and HCV.
|
Stat Med
|
2008
|
0.83
|
|
68
|
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).
|
AIDS
|
2015
|
0.82
|
|
69
|
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.
|
Hepatology
|
2009
|
0.82
|
|
70
|
The life span of ganglionic glia in murine sensory ganglia estimated by uptake of bromodeoxyuridine.
|
Exp Neurol
|
2004
|
0.81
|
|
71
|
Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.
|
Semin Immunol
|
2013
|
0.80
|
|
72
|
Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection.
|
PLoS Comput Biol
|
2009
|
0.79
|
|
73
|
Kinetics of major histocompatibility class I antigen presentation in acute infection.
|
J Immunol
|
2009
|
0.78
|
|
74
|
Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase.
|
J Hepatol
|
2002
|
0.77
|
|
75
|
The fate of CD4+ T cells under tolerance-inducing stimulation: a modeling perspective.
|
Immunol Cell Biol
|
2013
|
0.76
|
|
76
|
Quantifying the activity of anti-HIV treatment in silico.
|
Nat Med
|
2012
|
0.75
|
|
77
|
The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.
|
Virology
|
2008
|
0.75
|